Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells

Toxicology and Applied Pharmacology

Volumn 151, Issue 1, 1998, Pages 135-142

  Maness, Susan C ^a   McDonnell, Donald P ^b   Gaido, Kevin W ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CHLORPHENOTANE; ESTRADIOL; FLUTAMIDE; HYDROXYFLUTAMIDE; METHOXYCHLOR; PROGESTERONE; TESTOSTERONE;

AGONIST; ARTICLE; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; DOSE RESPONSE; ENZYME ACTIVITY; ESTROGEN BINDING; HEPATOMA CELL; HUMAN; HUMAN CELL; LIGAND BINDING; PROTEIN DETERMINATION; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; REPRODUCIBILITY;

EID: 0031752451     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8431     Document Type: Article

References (43)

1. Bulger, W. H., and Kupfer, D. (1983). Estrogenic action of DDT analogs. Am. J. Ind. Med. 4, 163-173.
2. Bulger, W. H., Muccitelli, R. M., and Kupper, D. (1978). Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation. Biochem. Pharmacol. 27, 2417-2423.
3. Chen, C. W., Hurd, C., Vorojeikina, D. P., Arnold, S. F., and Notides, A. C. (1997). Transcriptional activation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem. Pharmacol. 53, 1161-1172.
4. Colburn, T., vom Saal, F. S., and Soto, A. M. (1993). Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378-384.
5. Doesburg, P., Kuil, C. W., Berrevoets, C. A., Steketee, K., Faber, P. W., Mulder, E., Brinkmann, A. O., and Trapman, J. (1997). Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36, 1052-1064.
6. Edwards, D. P., Altmann, M., DeMarzo, A., Zhang, Y., Weigel, N. L., and Beck, C. A. (1995). Progesterone receptor and the mechanism of action of progesterone antagonists. J. Steroid Biochem. Mol. Biol. 53, 449-458.
7. Eil, C., and Nisula, B. C. (1990). The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J. Steroid Biochem. 35, 409-414.
8. Forster, M. S., Wilder, E. L., and Heinrichs, W. L. (1975). Estrogenic behavior of 2(o-chlorophenyl)-2-(p-chlorophenyl)-1,1,1-trichloroethane and its homologues. Biochem. Pharmacol. 24, 1777-1780.
9. Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and McDonnell, D. P. (1997). Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205-212.
10. Hammond, B., Katzenellenbogen, B. S., Krauthammer, N., and McConnell, J. (1979). Estrogenic activity of the insecticide chlordecone (kepone) and interaction with uterine estrogen receptors. Proc. Natl. Acad. Sci. USA 76, 6641-6645.
11. Hosokawa, S., Murakami, M., Ineyama, M., Yamada, T., Yoshitake, A., Yamada, H., and Miyamoto, J. (1993). The affinity of procymidone to androgen receptor in rats and mice. J. Toxicol. Sci. 18, 83-93.
12. Ing, N. H., and O'Malley, B. W. (1995). The steroid hormone receptor superfamily - molecular mechanisms of action. In Molecular Endocrinology: Basic Concepts and Clinical Correlations, (B. Weintraub, Ed.), pp. 195-215. Raven Press, New York.
13. Jensen, T. K., Toppari, J., Keiding, N., and Skakkebaek, N. E. (1995). Do environmental estrogens contribute to the decline in male reproductive health? Clin. Chem. 41, 1896-1901.
14. Katzenellenbogen, J. A., O'Malley, B. W., and Katzenellenbogen, B. S. (1996). Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10, 119-131.
15. Kelce, W. R. (1997). Vinclozolin and p,p′-DDE alter androgen-dependent gene expression: In vivo confirmation of an androgen receptor-mediated mechanism. Toxicol. Appl. Pharmacol. 142, 192-200.
16. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M. (1995). Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375, 581-585.
17. Kelce, W. R., and Wilson, E. M. (1997). Environmental antiandrogens: Developmental effects, molecular mechanisms, and clinical implications. J. Mol. Med. Immunol. 75, 198-207.
18. Kemppainen, J. A., Lane, M. V., Sar, M., and Wilson, E. M. (1992). Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267, 968-974.
19. Kemppainen, J. A., and Wilson, E. M. (1996). Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. Urology 48, 157-163.
20. Korach, K. S., Sarver, P., Chae, K., McLachlan, J. A., and McKinney, J. D. (1988). Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: Conformationally restricted structural probes. Mol. Pharmacol. 33, 120-126.
21. Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L., and Feldman, D. (1993). Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132, 2279-2286.
22. Kuil, C. W., Berrevoets, C. A., and Mulder, E. (1995). Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization - studies on the mechanism of antiandrogen action. J. Biol. Chem. 270, 27569-27576.
23. Kuil, C. W., and Mulder, E. (1994). Mechanism of antiandrogen action: Conformational changes of the receptor. Mol. Cell. Endocrinol. 102, R1-5.
24. Kuil, C. W., and Mulder, E. (1995). Effects of androgens and antiandrogens on the conformation of the androgen receptor. Ann. NY Acad. Sci. 761, 351-354.
25. Langley, E., Zhou, Z. X., and Wilson, E. M. (1995). Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270, 29983-29990.
26. McDonnell, D. P., Clemm, D. L., Herman, T., Goldman, M. E., and Pike, J. W. (1995). Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9, 659-669.
27. Moore, M., Mustain, M., Daniel, K., Chen, I., Safe, S., Zacharewski, T., Gillesby, B., Joyeux, A., and Balaguer, P. (1997). Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol. Appl. Pharmacol. 142, 160-168.
28. Nagel, S. C., vom Saal, F. S., Thayer, K. A., Dhar, M. G., Boechler, M., and Welshons, W. V. (1997). Relative binding affinity serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 105, 70-76.
29. Norris, J. D., Fan, D. J., Wagner, B. L., and McDonnell, D. P. (1996). Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol. Endocrinol. 10, 1605-1616.
30. Raddatz, D., Henneken, M., Armbrust, T., and Ramadori, G. (1996). Subcellular distribution of glucocorticoid receptor in cultured rat and human liver-derived cells and cell lines: Influence of dexamethasone. Hepatology 24, 928-933.
31. Ramamoorthy, K., Vyhlidal, C., Wang, F., Chen, I. C., Safe, S., McDonnell, D. P., Leonard, L. S., and Gaido, K. W. (1997). Additive estrogenic activities of a binary mixture of 2′,4′,6′-trichloro- and 2′,3′,4′,5′-tetrachloro-4- biphenylol. Toxicol. Appl. Pharmacol. 147, 93-100.
32. Robison, A. K., Schmidt, W. A., and Stancel, G. M. (1985). Estrogenic activity of DDT: Estrogen-receptor profiles and the responses of individual uterine cell types following o,p′-DDT administration. J. Toxicol. Environ. Health 16, 493-508.
33. Sharpe, R. M., and Skakkebaek, N. F. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 341, 1392-1395.
34. Soto, A. M., Honorato, J., Wray, J. W., and Sonnenschein, C. (1991). Nonylphenol: An estrogenic xenobiotic released from "modified" polystyrene. Environ. Health Perspect. 92, 167-173.
35. Tzukerman, M. T., Esty, A., Santiso-Mere, D., Danielian, P., Parker, M. G., Stein, R. B., Pike, J. W., and McDonnell, D. P. (1994). Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8, 21-30.
36. Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., and McDonnell, D. P. (1993). Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7, 1244-1255.
37. Welch, R. M., Levin, W., and Conney, A. H. (1969). Estrogenic action of DDT and its analogs. Toxicol. Appl. Pharmacol. 14, 358-367.
38. White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G. (1994). Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135, 175-181.
39. Wolff, M. S., and Toniolo, P. G. (1995). Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ. Health Perspect. 103, 141-145.
40. Wong, C. I., Kelce, W. R., Sar, M., and Wilson, E. M. (1995). Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270, 19998-20003.
41. Yeh, S., Miyamoto, H., and Chang, C. (1997). Hydroxyflutamide may not always be a pure antiandrogen [letter]. Lancet 349, 852-853.
42. Yeh, S. Y., and Chang, C. S. (1996). Cloning and characterization of a specific coactivator, ARA(70), for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93, 5517-5521.
43. Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., and Wilson, E. M. (1995). Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9, 208-218.